NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Apr 4, 2017
Insider Transaction Report
Form 4
Brown Robert S.
Sr. Vice President, CFO
Transactions
- Sale
Common Stock
2017-04-03$26.60/sh−14,397$382,960→ 13,606 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-04-03−11,917→ 59,592 totalExercise: $15.58From: 2016-04-09Exp: 2026-03-08→ Common Stock (11,917 underlying) - Exercise/Conversion
Common Stock
2017-04-03$15.58/sh+11,917$185,667→ 28,003 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.